0 results for 'Celgene'
MSP Recovery Claims v. Celgene Corp.
Publication Date: 2024-04-26 Practice Area: Antitrust
Industry:
Court: U.S. District Court for New Jersey Judge: Magistrate Judge Hammer Attorneys: For plaintiff: For defendant: Case number: 21-20451 (ES) (MAH)
Plaintiffs filed objections to the special discovery master's decision.
In re Bristol-Myers Squibb Co. CVR Sec. Litig.
Publication Date: 2024-03-08 Practice Area: Securities Litigation
Industry:
Court: U.S. District Court for the Southern District of New York, U.S. - SDNY Judge: District Judge Jesse M. Furman Attorneys: For plaintiff: For defendant: Case number: 21-CV-8255
Plaintiffs Fail to Allege Bristol-Myers Squibb Defendants Acted with Requisite Scienter
Mayo Clinic, Lifepoint Claim Drugmakers Conspired to Delay Generic Competition for Chemo Drug
This suit was surfaced by Law.com Radar. Read the complaint here.
Litigator of the Week Runners-Up and Shout Outs
Runners-up this week include teams from Williams & Connolly, Kramer Levin Naftalis & Frankel, and Singer Cashman.
Paul Weiss Adds Former Wachtell Executive Compensation Partner in New York
Andrea Wahlquist Brown has decades of experience at both Wachtell and Simpson Thacher.
Law Journal Press | Digital Book
State Antitrust Law
Authors: William T. Lifland
View this Book
View more book results for the query "Celgene"
MSP Recovery Claims, Series LLC v. Celgene Corp.
Publication Date: 2023-05-04 Practice Area: Antitrust
Industry:
Court: U.S. District Court for New Jersey Judge: Magistrate Judge Hammer Attorneys: For plaintiff: For defendant: Case number: 21-20451 (ES) (MAH)
Charity defendants moved to sever in a class action brought by Medicare Advantage Heath Plans alleging an anticompetitive scheme to monopolize the market for two drugs.
$763 Per Pill: Lawsuit Accuses Drugmakers of Scheme Involving Cancer Medicine Revlimid
"Defendants' settlement agreement constitutes a horizontal output-restriction and market-allocation agreement—a per se violation of the Sherman Act," the suit says.
Bernstein v. Bristol-Myers Squibb Co.
Publication Date: 2022-09-30 Practice Area: Civil Procedure |
Securities Litigation
Industry:
Court: U.S. District Court for New Jersey Judge: District Judge McNulty Attorneys: For plaintiff: For defendant: Case number: 21-20452 (KM) (CLW)
Defendants moved to transfer venue and plaintiff moved to remand his putative class action asserting defendant's Form S-4 registration filed with the SEC pertaining to Contingent Value Rights was false and misleading.
'Don't Leave the Junky Work to Somebody Else': A Veteran Legal Chief Shares Leadership Lessons
"I believe firmly in training each person in the legal department to take over from me—to be my successor," said Stephen Kim, chief legal officer of Avicanna.
Selendy Gay Elsberg's Newest Name Partners Dig Into the Boutique's One-Office Approach
"Among our partners, we have a very deliberate group of people who have chosen to work together—over the course of decades, in fact," says Jennifer Selendy who was co-managing partner of Selendy Gay Elsberg alongside David Elsberg for the boutique's first four years of existence. They joined Philippe Selendy and Faith Gay as name partners at the beginning of this year.TRENDING STORIES
More from ALM
- Legal Speak at General Counsel Conference Midwest 2024: Mike Andolina, Partner, White & Case 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Carolyn Burbrink, Uber Director of Volume Mobility Safety and Insurance Litigation 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Vaishali Rao, Hinshaw & Culbertson Partner 1 minute read
Resources
Corporate Transparency Act Resource Kit
Brought to you by Wolters Kluwer
Download Now
Revenue, Profit, Cash: Managing Law Firms for Success
Brought to you by Juris Ledger
Download Now
Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now